Literature DB >> 25766063

Application of the IHI Global Trigger Tool in measuring the adverse event rate in a Turkish healthcare setting.

Mehmet Nurullah Kurutkan1, Esra Usta2, Fatih Orhan3, M C Emre Simsekler4.   

Abstract

BACKGROUND: The goal of this study was to measure an adverse event rate and determine the potential usefulness of the Institute for Healthcare Improvement's Global Trigger Tool (GTT). Besides using the GTT to measure the adverse event rate, a comparison was also made with the internal Voluntary Reporting Notification System (VRNS) to identify and compare the strengths and weaknesses of the two approaches.
METHOD: Retrospective data were collected from reported patient safety incidents covering a one-year period at Duzce University Hospital, Turkey. Using a range of selection criteria, a total of 219 patient records were selected and then reviewed by a trained GTT team, to investigate the positive triggers in the content of the patient records.
RESULTS: It was determined that adverse events per 1000 patient days totalled 80.72. Adverse events per 100 admissions were 29.39, and the rate of admissions with adverse events was 16.67%. The comparison between the GTT and the VRNS showed that the GTT is 19 times more sensitive than the VRNS in the adverse event evaluation process.
CONCLUSION: This is the first published study of the rate of adverse events in a Turkish healthcare setting using the GTT. It was found that the GTT was applicable in this setting, yielding more accurate measurement of the adverse event rate. However, the content of the GTT should be adjusted regarding the standards and documentations used in the Turkish healthcare system to be more useful.

Entities:  

Keywords:  IHI Global Trigger Tool; Patient safety; adverse event

Mesh:

Year:  2015        PMID: 25766063     DOI: 10.3233/JRS-150639

Source DB:  PubMed          Journal:  Int J Risk Saf Med        ISSN: 0924-6479


  8 in total

1.  The ability of triggers to retrospectively predict potentially preventable adverse events in a sample of deceased patients.

Authors:  Dorthe O Klein; Roger J M W Rennenberg; Richard P Koopmans; Martin H Prins
Journal:  Prev Med Rep       Date:  2017-11-03

2.  A Systematic Review of Methods for Medical Record Analysis to Detect Adverse Events in Hospitalized Patients.

Authors:  Dorthe O Klein; Roger J M W Rennenberg; Richard P Koopmans; Martin H Prins
Journal:  J Patient Saf       Date:  2021-12-01       Impact factor: 2.243

3.  Variation in detected adverse events using trigger tools: A systematic review and meta-analysis.

Authors:  Luisa C Eggenschwiler; Anne W S Rutjes; Sarah N Musy; Dietmar Ausserhofer; Natascha M Nielen; René Schwendimann; Maria Unbeck; Michael Simon
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

4.  Evaluating inputs of failure modes and effects analysis in identifying patient safety risks.

Authors:  Mecit Can Emre Simsekler; Gulsum Kubra Kaya; James R Ward; P John Clarkson
Journal:  Int J Health Care Qual Assur       Date:  2019-02-11

5.  Design for patient safety: a systems-based risk identification framework.

Authors:  M C Emre Simsekler; James R Ward; P John Clarkson
Journal:  Ergonomics       Date:  2018-02-15       Impact factor: 2.778

6.  Evaluation of system mapping approaches in identifying patient safety risks.

Authors:  Mecit Can Emre Simsekler; James R Ward; P John Clarkson
Journal:  Int J Qual Health Care       Date:  2018-04-01       Impact factor: 2.038

Review 7.  A 50-Year Overview of the Coronavirus Family with Science Mapping Techniques: A Review.

Authors:  Ayhan Tabur; Ali Arslanoğlu
Journal:  Iran J Public Health       Date:  2021-04       Impact factor: 1.429

8.  Occurrence of No-Harm Incidents and Adverse Events in Hospitalized Patients with Ischemic Stroke or TIA: A Cohort Study Using Trigger Tool Methodology.

Authors:  Bartosch Nowak; René Schwendimann; Philippe Lyrer; Leo H Bonati; Gian Marco De Marchis; Nils Peters; Franziska Zúñiga; Lili Saar; Maria Unbeck; Michael Simon
Journal:  Int J Environ Res Public Health       Date:  2022-02-27       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.